Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production

HJ. Vreman, S. Kourula, J. Jašprová, L. Ludvíková, P. Klán, L. Muchová, L. Vítek, BK. Cline, RJ. Wong, DK. Stevenson,

. 2019 ; 85 (6) : 865-873. [pub] 20190126

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 1967 to 1 year ago
ProQuest Central from 2016-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2016-01-01 to 1 year ago
Public Health Database (ProQuest) from 2016-01-01 to 1 year ago

BACKGROUND: The action spectrum for bilirubin photodegradation has been intensively studied. However, questions still remain regarding which light wavelength most efficiently photodegrades bilirubin. In this study, we determined the in vitro effects of different irradiation wavelength ranges on bilirubin photodegradation. METHODS: In our in vitro method, normalized absolute irradiance levels of 4.2 × 1015 photons/cm2/s from light-emitting diodes (ranging from 390-530 nm) and 10-nm band-pass filters were used to irradiate bilirubin solutions (25 mg/dL in 4% human serum albumin). Bilirubin and its major photoisomer concentrations were determined; the half-life time of bilirubin (t1/2) was calculated for each wavelength range, and the spectral characteristics for bilirubin photodegradation products were obtained for key wavelengths. RESULTS: The in vitro photodegradation of bilirubin at 37 °C decreased linearly as the wavelength was increased from 390 to 500 nm with t1/2 decreasing from 63 to 17 min, respectively. At 460 ± 10 nm, a significantly lower rate of photodegradation and thus higher t1/2 (31 min) than that at 500 nm (17 min) was demonstrated. CONCLUSION: In our system, the optimum bilirubin photodegradation and lumirubin production rates occurred between 490 and 500 nm. Spectra shapes were remarkably similar, suggesting that lumirubin production was the major process of bilirubin photodegradation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022765
003      
CZ-PrNML
005      
20201214124754.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41390-019-0310-2 $2 doi
035    __
$a (PubMed)30710116
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vreman, Hendrik J $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA. henk.vreman@stanford.edu.
245    14
$a The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production / $c HJ. Vreman, S. Kourula, J. Jašprová, L. Ludvíková, P. Klán, L. Muchová, L. Vítek, BK. Cline, RJ. Wong, DK. Stevenson,
520    9_
$a BACKGROUND: The action spectrum for bilirubin photodegradation has been intensively studied. However, questions still remain regarding which light wavelength most efficiently photodegrades bilirubin. In this study, we determined the in vitro effects of different irradiation wavelength ranges on bilirubin photodegradation. METHODS: In our in vitro method, normalized absolute irradiance levels of 4.2 × 1015 photons/cm2/s from light-emitting diodes (ranging from 390-530 nm) and 10-nm band-pass filters were used to irradiate bilirubin solutions (25 mg/dL in 4% human serum albumin). Bilirubin and its major photoisomer concentrations were determined; the half-life time of bilirubin (t1/2) was calculated for each wavelength range, and the spectral characteristics for bilirubin photodegradation products were obtained for key wavelengths. RESULTS: The in vitro photodegradation of bilirubin at 37 °C decreased linearly as the wavelength was increased from 390 to 500 nm with t1/2 decreasing from 63 to 17 min, respectively. At 460 ± 10 nm, a significantly lower rate of photodegradation and thus higher t1/2 (31 min) than that at 500 nm (17 min) was demonstrated. CONCLUSION: In our system, the optimum bilirubin photodegradation and lumirubin production rates occurred between 490 and 500 nm. Spectra shapes were remarkably similar, suggesting that lumirubin production was the major process of bilirubin photodegradation.
650    _2
$a bilirubin $x analogy a deriváty $x krev $x chemie $x účinky záření $7 D001663
650    _2
$a lidé $7 D006801
650    _2
$a novorozenecká hyperbilirubinemie $x krev $x terapie $7 D051556
650    _2
$a techniky in vitro $7 D066298
650    _2
$a novorozenec $7 D007231
650    _2
$a isomerie $7 D007536
650    12
$a světlo $7 D008027
650    _2
$a fotolýza $x účinky záření $7 D010782
650    _2
$a fototerapie $x metody $7 D010789
650    _2
$a lidský sérový albumin $x chemie $x účinky záření $7 D000075462
650    _2
$a spektrofotometrie $7 D013053
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kourula, Stephanie $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
700    1_
$a Jašprová, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic.
700    1_
$a Ludvíková, Lucie $u Department of Chemistry and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
700    1_
$a Klán, Petr $u Department of Chemistry and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
700    1_
$a Muchová, Lucie $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic.
700    1_
$a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic. vitek@cesnet.cz.
700    1_
$a Cline, Benjamin K $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
700    1_
$a Wong, Ronald J $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
700    1_
$a Stevenson, David K $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
773    0_
$w MED00003741 $t Pediatric research $x 1530-0447 $g Roč. 85, č. 6 (2019), s. 865-873
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30710116 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214124754 $b ABA008
999    __
$a ok $b bmc $g 1595084 $s 1113441
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 85 $c 6 $d 865-873 $e 20190126 $i 1530-0447 $m Pediatric research $n Pediatr Res $x MED00003741
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...